World's Best Scientists 2026 revealed!
Gilles Tamagnan

Gilles Tamagnan

D-Index & Metrics

Neuroscience

D-Index
40
Citations
6181
World Ranking
8107
National Ranking
3477

Gilles Tamagnan publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Gilles Tamagnan sits on this spectrum.

38–47 publications: 18 scientists 48–57 publications: 79 scientists 58–67 publications: 193 scientists 68–77 publications: 323 scientists 78–87 publications: 406 scientists 88–97 publications: 452 scientists 98–107 publications: 539 scientists 108–117 publications: 505 scientists 118–127 publications: 522 scientists 128–137 publications: 469 scientists 138–147 publications: 456 scientists 148–157 publications: 459 scientists 158–167 publications: 397 scientists 168–177 publications: 383 scientists 178–187 publications: 350 scientists 188–197 publications: 302 scientists 198–207 publications: 306 scientists 208–217 publications: 262 scientists 218–227 publications: 242 scientists 228–237 publications: 220 scientists 238–247 publications: 203 scientists 248–257 publications: 174 scientists 258–267 publications: 176 scientists 268–277 publications: 175 scientists 278–287 publications: 125 scientists 288–297 publications: 116 scientists 298–307 publications: 127 scientists 308–317 publications: 128 scientists 318–327 publications: 99 scientists 328–337 publications: 89 scientists 338–347 publications: 78 scientists 348–357 publications: 96 scientists 358–367 publications: 66 scientists 368–377 publications: 59 scientists 378–387 publications: 65 scientists 388–397 publications: 54 scientists 398–407 publications: 48 scientists 408–417 publications: 49 scientists 418–427 publications: 34 scientists 428–437 publications: 31 scientists 438–447 publications: 30 scientists 448–457 publications: 31 scientists 458–467 publications: 36 scientists 468–477 publications: 40 scientists 478–487 publications: 35 scientists 488–497 publications: 30 scientists 498–507 publications: 23 scientists 508–517 publications: 26 scientists 518–527 publications: 20 scientists 528–537 publications: 23 scientists 538–547 publications: 20 scientists 548–557 publications: 20 scientists 558–567 publications: 17 scientists 568–577 publications: 14 scientists 578–587 publications: 20 scientists 588–597 publications: 20 scientists 598–607 publications: 19 scientists 608–617 publications: 18 scientists 618–627 publications: 17 scientists 628–637 publications: 11 scientists 638–647 publications: 11 scientists 648–657 publications: 11 scientists 658–667 publications: 8 scientists 668–677 publications: 7 scientists 678–687 publications: 11 scientists 688–697 publications: 10 scientists 698–707 publications: 4 scientists 708–717 publications: 6 scientists 718–727 publications: 5 scientists 728–737 publications: 5 scientists 738–747 publications: 9 scientists 748–757 publications: 9 scientists 758–767 publications: 3 scientists 768–777 publications: 7 scientists 778–787 publications: 7 scientists 788–797 publications: 6 scientists 798–807 publications: 2 scientists 808–817 publications: 2 scientists 818–827 publications: 7 scientists 828–837 publications: 0 scientists 838–847 publications: 9 scientists 848–857 publications: 3 scientists 858–867 publications: 1 scientists 868–877 publications: 3 scientists 878–886 publications: 6 scientists 887+ publications: 100 scientists
38 publications 887+

This scientist: 213 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Gilles Tamagnan D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Gilles Tamagnan sits on this spectrum.

30–31 D-Index: 42 scientists 32–33 D-Index: 172 scientists 34–35 D-Index: 296 scientists 36–37 D-Index: 435 scientists 38–39 D-Index: 459 scientists 40–41 D-Index: 456 scientists 42–43 D-Index: 467 scientists 44–45 D-Index: 478 scientists 46–47 D-Index: 512 scientists 48–49 D-Index: 435 scientists 50–51 D-Index: 425 scientists 52–53 D-Index: 418 scientists 54–55 D-Index: 392 scientists 56–57 D-Index: 357 scientists 58–59 D-Index: 334 scientists 60–61 D-Index: 328 scientists 62–63 D-Index: 260 scientists 64–65 D-Index: 278 scientists 66–67 D-Index: 239 scientists 68–69 D-Index: 250 scientists 70–71 D-Index: 210 scientists 72–73 D-Index: 200 scientists 74–75 D-Index: 189 scientists 76–77 D-Index: 170 scientists 78–79 D-Index: 146 scientists 80–81 D-Index: 113 scientists 82–83 D-Index: 126 scientists 84–85 D-Index: 100 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 99 scientists 90–91 D-Index: 84 scientists 92–93 D-Index: 85 scientists 94–95 D-Index: 72 scientists 96–97 D-Index: 76 scientists 98–99 D-Index: 45 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 43 scientists 104–105 D-Index: 32 scientists 106–107 D-Index: 45 scientists 108–109 D-Index: 50 scientists 110–111 D-Index: 32 scientists 112–113 D-Index: 39 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 27 scientists 120–121 D-Index: 19 scientists 122–123 D-Index: 23 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 16 scientists 128–129 D-Index: 24 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 21 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 14 scientists 138–139 D-Index: 15 scientists 140–141 D-Index: 10 scientists 142–143 D-Index: 10 scientists 144–145 D-Index: 13 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 8 scientists 150–151 D-Index: 6 scientists 152–153 D-Index: 6 scientists 154–155 D-Index: 7 scientists 156–157 D-Index: 7 scientists 158–159 D-Index: 10 scientists 160–161 D-Index: 4 scientists 162 D-Index: 8 scientists 163+ D-Index: 100 scientists
30 D-Index 163+

This scientist: 40 D-Index — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Overview

Gilles Tamagnan is affiliated with Yale University in the United States and has a research focus spanning medicine, biochemistry, genetics, molecular biology, and neuroscience. Their work integrates several subfields including cellular and molecular neuroscience, neurology, molecular biology, genetics, and radiology, nuclear medicine, and imaging.

The scientist's main topics of study include:

  • Neuroscience and Neuropharmacology Research
  • Parkinson's Disease Mechanisms and Treatments
  • Neurological disorders and treatments
  • Medical Imaging Techniques and Applications
  • Nuclear Receptors and Signaling
  • Pharmacological Receptor Mechanisms and Effects
  • Cholesterol and Lipid Metabolism

The recent scholarly contributions of Gilles Tamagnan feature research published in respected journals, covering a range of subjects related to neuroinflammation, imaging, and receptor studies. Notable papers include:

  • "Brain microglia activation and peripheral adaptive immunity in Parkinson's disease: a multimodal PET study," 2022, Journal of Neuroinflammation
  • "Rapidly (and Successfully) Translating Novel Brain Radiotracers From Animal Research Into Clinical Use," 2020, Frontiers in Neuroscience
  • "Preclinical characterization of [18F]T-008, a novel PET imaging radioligand for cholesterol 24-hydroxylase," 2021, European Journal of Nuclear Medicine and Molecular Imaging
  • "Diagnostic value of striatal 18F-FP-DTBZ PET in Parkinson's disease," 2022, Frontiers in Aging Neuroscience
  • "Evaluation of (rac)-, (R)-, and (S)-18F-OF-NB1 for Imaging GluN2B Subunit-Containing N-Methyl-d-Aspartate Receptors in Nonhuman Primates," 2022, Journal of Nuclear Medicine

Frequent collaborators in their research include:

  • Olivier Barret
  • Shuying Liu
  • Hongwen Qiao
  • Tatsuki Koike
  • Cristian Constantinescu

Gilles Tamagnan's publications commonly appear in the following venues:

  • Journal of Nuclear Medicine
  • European Journal of Nuclear Medicine and Molecular Imaging
  • Frontiers in Aging Neuroscience
  • Journal of Medicinal Chemistry
  • Journal of Neuroinflammation

Their research contributions primarily address neurological conditions such as Parkinson's disease through advanced imaging techniques, receptor characterization, and neuropharmacology. The integration of nuclear imaging methods like PET in neurological and molecular studies is a significant aspect of their work.

Best Publications

  • Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

    Julie K. Staley;Suchitra Krishnan-Sarin;Sami Zoghbi;Gilles Tamagnan

  • Human tobacco smokers in early abstinence have higher levels of beta2* nicotinic acetylcholine receptors than nonsmokers.

    Julie K. Staley;Suchitra Krishnan-Sarin;Kelly P. Cosgrove;Erica Krantzler

  • 5-Iodo-A-85380, an α4β2 Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

    Alexey G. Mukhin;Daniela Gündisch;Andrew G. Horti;Andrei O. Koren

  • Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study

    Andre Mueller;Santiago Bullich;Olivier Barret;Jennifer Madonia

  • Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies

    Heiko Kroth;Felix Oden;Jerome Molette;Hanno Schieferstein

  • One-step synthesis of 2-arylbenzothiazole (‘BTA’) and -benzoxazole precursors for in vivo imaging of β-amyloid plaques

    David Alagille;Ronald M. Baldwin;Gilles D. Tamagnan;Gilles D. Tamagnan

  • Substituent effects of N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamides on positive allosteric modulation of the metabotropic glutamate-5 receptor in rat cortical astrocytes.

    Tomas de Paulis;Kamondanai Hemstapat;Yelin Chen;Yongqin Zhang

  • A close structural analog of 2-methyl-6-(phenylethynyl)-pyridine acts as a neutral allosteric site ligand on metabotropic glutamate receptor subtype 5 and blocks the effects of multiple allosteric modulators.

    Alice L. Rodriguez;Yi Nong;Nishant K. Sekaran;David Alagille

  • β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking

    Kelly P. Cosgrove;Jeffery Batis;Frederic Bois;Paul K. Maciejewski

  • Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex.

    Lucas Lecourtier;Houman Homayoun;Gilles Tamagnan;Bita Moghaddam

  • Sex differences in diencephalon serotonin transporter availability in major depression.

    Julie K. Staley;Gerard Sanacora;Gilles Tamagnan;Paul K. Maciejewski

  • Persistent β2*-Nicotinic Acetylcholinergic Receptor Dysfunction in Major Depressive Disorder

    Aybala Saricicek;Irina Esterlis;Kathleen H. Maloney;Yann S. Mineur

  • Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

    Gunasingh J. Masilamoni;James W. Bogenpohl;David Alagille;Kristen Delevich

  • The Phosphodiesterase 10 Positron Emission Tomography Tracer, [18F]MNI-659, as a Novel Biomarker for Early Huntington Disease

    David S. Russell;Olivier Barret;Danna L. Jennings;Joseph H. Friedman

  • [18F]GTP1 (Genentech Tau Probe 1), a radioligand for detecting neurofibrillary tangle tau pathology in Alzheimer's disease.

    Sandra Sanabria Bohórquez;Jan Marik;Annie Ogasawara;Jeff N Tinianow

  • N-Substituted Analogs of 2β-Carbomethoxy-3β-(4‘-iodophenyl)tropane (β-CIT) with Selective Affinity to Dopamine or Serotonin Transporters in Rat Forebrain

    John L. Neumeyer;Gilles Tamagnan;Shaoyin Wang;Yigong Gao

  • Radiosynthesis of [18F] N-3-fluoropropyl-2-β-carbomethoxy-3-β-(4-iodophenyl) nortropane and the first human study with positron emission tomography

    Thomas Chaly;Vijay Dhawan;Ken Kazumata;Angelo Antonini

  • Local anesthetic effects of cocaethylene and isopropylcocaine on rat peripheral nerves.

    Hajime A. Tokuno;Charles W. Bradberry;Brian Everill;Samuel K. Agulian

  • Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.

    Yaping Chu;Scott Muller;Adriana Tavares;Olivier Barret

  • A Novel Family of Potent Negative Allosteric Modulators of Group II Metabotropic Glutamate Receptors

    Kamondanai Hemstapat;Herve Da Costa;Yi Nong;Ashley E. Brady

  • Whole-body biodistribution, radiation absorbed dose, and brain SPET imaging with [123i]5-i-A-85380 in healthy human subjects.

    Masahiro Fujita;John P. Seibyl;Bruce D. Vaupel;Gilles Tamagnan

Frequent Co-Authors

John Seibyl
John Seibyl Yale University
Danna Jennings
Danna Jennings Denali Therapeutics (United States)
Kenneth Marek
Kenneth Marek Institute for Neurodegenerative Disorders
Robert B. Innis
Robert B. Innis National Institutes of Health
Kelly P. Cosgrove
Kelly P. Cosgrove Yale University
Ross J. Baldessarini
Ross J. Baldessarini Harvard University
Stephanie S. O'Malley
Stephanie S. O'Malley Yale University
John L. Neumeyer
John L. Neumeyer Harvard University
David W. Russell
David W. Russell University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring neuroscience opens doors to multiple related online degrees and career options in the broader fields of psychology, therapy, and social work. For those interested in mental health care, online mft programs accredited offer flexible pathways to become a licensed marriage and family therapist. These programs typically provide practical training with a neuroscience-informed perspective.

Considering an advanced degree? It's important to evaluate how much does a masters in psychology cost, as tuition varies widely between institutions. Budget and program flexibility should align with your career aspirations.

Undergraduate psychology degrees are another accessible start for students planning to transition into neuroscience or other mental health professions. These degrees build foundational knowledge, critical for more specialized graduate study.

If you are passionate about community mental health, an msw online degree (Master of Social Work) can also complement a neuroscience background, leading to impactful roles in clinical settings and advocacy work.

Best Scientists Citing Gilles Tamagnan

Trending Scientists

Recently Published Articles